请选择 进入手机版 | 继续访问电脑版
【试管之家】 门户 新闻 国际新闻 查看内容

HFEA公布了更新生育法的计划

游海 2021-12-28 11:31 试管之家 查看: 64 评论: 0

摘要:   在人类受精和胚胎学管理局(HFEA)有详细的潜力更新关于在英国的生育治疗措施,包括改善患者保护的现行法律。  该公告是HFEA主席Julia Chain在Progress Educational Trust(PET,出版BioNews的慈善机构)年会 ...
  在人类受精和胚胎学管理局(HFEA)有详细的潜力更新关于在英国的生育治疗措施,包括改善患者保护的现行法律。

  该公告是HFEA主席Julia Chain在Progress Educational Trust(PET,出版BioNews的慈善机构)年会上发表的讲话中宣布的。她澄清说,1990年《人类受精和胚胎学法》制定了有关生育治疗和研究的法律(并在2008年进行了重大更新)的大部分内容仍然适用于目的。然而,她认为,鉴于医疗的巨大进步和社会态度的变化,该行业变得越来越难以监管。

  “自从该法案首次实施以来,生育部门确实发生了重大变化”,Chain在会议前在BBC电台4上告诉今日节目。“是时候让我们真正看看需要现代化的东西了。”

  Chain在她的演讲中指出,该法案不包含“任何与患者、患者安全甚至治疗结果相关的词”。作为监管者,她认为HFEA有责任“将所有这三件事放在我们工作的前沿”。

  PET主管Sarah Norcross对现代化的呼吁表示欢迎。她说:“我们决定召开我们的“生殖监管”会议,发言者包括HFEA和其他监管机构,因为管理生育治疗和相关研究的法律法规正在暴露他们的年龄。“这是一个绝佳的机会,可以阐明谁调节生育能力以及如何调节。”

  在她的演讲中,Chain强调了该法案中需要特别关注的几个领域。第一个涉及患者保护和维持为他们提供的护理质量。这将包括更广泛的解决绩效不佳的方法,例如对不合规诊所的经济制裁。这还包括解决生育部门日益商业化的问题,其中65%的治疗是自筹资金,公共资金分配不均,导致“邮政彩票”。

  在这个标题下,Chain还讨论了生育治疗的“附加”,以及这些可能导致患者混淆或容易受到诊所经济剥削的可能性。她解释说,就目前的情况而言,HFEA在生育治疗的这方面几乎没有权力——因此HFEA最近与竞争和市场管理局合作,后者的消费者保护主管在PET会议上与Chain一起发言。

  Chain谈到了其他几个她认为该法案不符合现代家庭和医学的领域,包括将母亲定义为“怀有或已经怀过孩子的女人”。这实际上排除了一些同性伴侣、跨性别父母和单亲父母。

  Chain还特别指出了14天规则,该规则要求用于研究的人类胚胎在其创造后的14天内销毁,以及有关生育治疗的信息具有医疗保密的特殊地位(超出患者的一般考虑)。保密)。

  Chain预计这些变化将取得快速进展,并表示“我们不是从一张白纸开始,该法案的大部分内容仍然适用于目的”。她补充说,她的目标是“明年与卫生和社会保健部就需要改变的内容达成大纲协议”。

一下原文:

  HFEA reveals plans to update fertility law

  The Human Fertilisation and Embryology Authority(HFEA)has detailed potential updates to current laws regarding fertility treatment practices in the UK,including improved patient protection.

  The announcement was made in a speech delivered by Julia Chain,chair of the HFEA,at the annual conference of the Progress Educational Trust(PET,the charity that publishes BioNews).She clarified that much of the Human Fertilisation and Embryology Act 1990,which established laws regarding fertility treatments and research(and was given a major update in 2008),remains suitable for purpose.However,she argued,the sector had become increasingly difficult to regulate,given substantial medical advances and changes in social attitudes.

  'The fertility sector has really changed significantly since the Act was first brought into being',Chain told the Today programme on BBC Radio 4 prior to the conference.'It's time we really had a look at what needs to be modernised.'

  In her speech,Chain pointed out that the Act does not contain'any words in it relating to patients,patient safety,or even outcomes of treatment'.As a regulator,she argued that it was the duty of the HFEA'to keep all those three things at the front of our work'.

  Sarah Norcross,director of PET,welcomed the call for modernisation.'We decided to hold our"Reproducing Regulation"conference,with speakers including the HFEA and other regulators,because the law and regulation that govern fertility treatment and related research are showing their age',she said.'This is a fantastic opportunity to clarify who regulates fertility,and how.'

  In her speech,Chain highlighted several areas of the Act that require particular focus.The first concerned patient protection and maintaining the quality of care provided for them.This would include a broader range of methods for addressing poor performance,such as economic sanctions against non-compliant clinics.This would also include addressing the increasing commercialisation of the fertility sector,where 65 percent of treatments are self-funded and public funding is poorly distributed,resulting in a'postcode lottery'.

  Under this heading,Chain also addressed fertility treatment'add-ons',and the possibility that these may contribute to patient confusion or vulnerability to financial exploitation by clinics.She explained that as things currently stand,the HFEA has little power over this aspect of fertility treatment–hence the HFEA's recent collaboration with the Competition and Markets Authority,whose director of consumer protection spoke alongside Chain at PET's conference.

  Chain touched on several other areas where she considered the Act to be out of step with modern families and medicine,including the definition of a mother as'the woman who is carrying or has carried a child'.This effectively excludes some same-sex couples,trans parents and single parents.

  Chain also singled out the 14-day rule,which requires human embryos used in research to be destroyed within 14 days of their creation,and the fact that information about fertility treatment has a special status of medical secrecy(over and above ordinary considerations of patient confidentiality).

  Chain anticipated that quick progress would be made bringing about these changes,saying that'we are not starting with a blank sheet of paper and much of the Act remains fit for purpose'.She added that her aim is'to reach an outline agreement with the Department of Health and Social Care next year on what needs to change.'

鲜花

握手

雷人

路过

鸡蛋

试友评论文明上网理性发言

微信 QQ好友 QQ空间 新浪微博 豆瓣 更多平台